We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Phase III trial of docetaxel plus gemcitabine versus docetaxel in second-line treatment for non-small-cell lung cancer: results of a Japan Clinical Oncology Group trial (JCOG0104).
- Authors
Takeda, K; Negoro, S; Tamura, T; Nishiwaki, Y; Kudoh, S; Yokota, S; Matsui, K; Semba, H; Nakagawa, K; Takada, Y; Ando, M; Shibata, T; Saijo, N
- Abstract
This trial evaluated whether a combination of docetaxel and gemcitabine provides better survival than docetaxel alone in patients with previously treated non-small-cell lung cancer (NSCLC).
- Publication
Annals of oncology : official journal of the European Society for Medical Oncology, 2009, Vol 20, Issue 5, p835
- ISSN
1569-8041
- Publication type
Journal Article
- DOI
10.1093/annonc/mdn705